Institutional shares held 62.5 Million
2.65M calls
1.1M puts
Total value of holdings $460M
$19.5M calls
$8.09M puts
Market Cap $406M
53,205,300 Shares Out.
Institutional ownership 117.38%
# of Institutions 245


Latest Institutional Activity in ARVN

Top Purchases

Q1 2025
Alyeska Investment Group, L.P. Shares Held: 1.8M ($13.7M)
Q1 2025
Nextech Invest, Ltd. Shares Held: 1.41M ($10.7M)
Q1 2025
Tang Capital Management LLC Shares Held: 1.39M ($10.6M)
Q1 2025
Vanguard Group Inc Shares Held: 8.36M ($63.8M)
Q1 2025
Philosophy Capital Management LLC Shares Held: 996K ($7.6M)

Top Sells

Q1 2025
T. Rowe Price Investment Management, Inc. Shares Held: 548K ($4.18M)
Q1 2025
Ubs Group Ag Shares Held: 475K ($3.63M)
Q1 2025
Jpmorgan Chase & CO Shares Held: 372K ($2.84M)
Q1 2025
Avidity Partners Management LP Shares Held: 413K ($3.15M)
Q1 2025
Price T Rowe Associates Inc Shares Held: 3.83M ($29.2M)

About ARVN

Arvinas, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of therapies to degrade disease-causing proteins. Its lead product candidates include Bavdegalutamide, a proteolysis targeting chimera (PROTAC) protein degrader that is in phase I clinical trial targeting the androgen receptor (AR) protein for the treatment of men with metastatic castration-resistant prostate cancer (mCRPC); ARV-471, a PROTAC protein degrader targeting the estrogen receptor protein for the treatment of patients with metastatic ER positive/HER2 negative breast cancer; and ARV-766 an investigational orally bioavailable PROTAC protein degrader for the treatment of men with mCRPC. The company has collaborations with Pfizer Inc., Genentech, Inc., F. Hoffman-La Roche Ltd., and Bayer AG. Arvinas, Inc. was founded in 2013 and is based in New Haven, Connecticut.


Insider Transactions at ARVN

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
655K Shares
From 14 Insiders
Grant, award, or other acquisition 655K shares
Sell / Disposition
63K Shares
From 6 Insiders
Open market or private sale 63K shares

Track Institutional and Insider Activities on ARVN

Follow ARVINAS, INC. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ARVN shares.

Notify only if

Insider Trading

Get notified when an Arvinas, Inc. insider buys or sells ARVN shares.

Notify only if

News

Receive news related to ARVINAS, INC.

Track Activities on ARVN